DONNIACUO, Maria
 Distribuzione geografica
Continente #
EU - Europa 875
NA - Nord America 769
AS - Asia 170
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.819
Nazione #
US - Stati Uniti d'America 766
IE - Irlanda 273
IT - Italia 260
GB - Regno Unito 86
UA - Ucraina 82
SG - Singapore 67
DE - Germania 60
CN - Cina 58
SE - Svezia 33
TR - Turchia 31
FI - Finlandia 26
GR - Grecia 19
BE - Belgio 16
KR - Corea 7
CZ - Repubblica Ceca 5
FR - Francia 5
BR - Brasile 4
NL - Olanda 4
IN - India 3
CA - Canada 2
DK - Danimarca 2
PT - Portogallo 2
VN - Vietnam 2
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
HK - Hong Kong 1
MK - Macedonia 1
Totale 1.819
Città #
Dublin 273
Chandler 184
Jacksonville 125
Naples 69
Ann Arbor 66
Singapore 45
Caserta 31
Princeton 26
Medford 24
Woodbridge 24
Santa Clara 23
Wilmington 23
Boardman 21
Aversa 19
Roxbury 18
Brussels 16
New York 16
Beijing 13
Bremen 13
Ashburn 11
Munich 11
Auburn Hills 8
San Mateo 8
Des Moines 7
Düsseldorf 7
Marano 7
Seoul 7
Cambridge 6
Campofelice di Roccella 6
Casale Monferrato 6
Hebei 6
Houston 6
Los Angeles 6
Mountain View 6
San Giorgio a Cremano 6
Brno 5
Crispano 5
Frattamaggiore 5
Milan 5
Boydton 4
Hanover 4
Kunming 4
London 4
Marano di Napoli 4
Rome 4
Venice 4
Amsterdam 3
Giugliano in Campania 3
Jinan 3
Lanzhou 3
Lappeenranta 3
Nanchang 3
Nanjing 3
Napoli 3
Zhengzhou 3
Arezzo 2
Capodrise 2
Dearborn 2
Dong Ket 2
Elora 2
Ercolano 2
Espoo 2
Fairfield 2
Haikou 2
Helsinki 2
Juelsminde 2
Lamezia Terme 2
Montesilvano Marina 2
Mumbai 2
Pannarano 2
Redwood City 2
Reggio Calabria 2
San Martino Sannita 2
Scafati 2
Shenyang 2
Torre del Greco 2
Valenza 2
Afragola 1
Altavilla Silentina 1
Amalfi 1
Anápolis 1
Avellino 1
Bacoli 1
Baronissi 1
Belo Horizonte 1
Borås 1
Brusciano 1
Catania 1
Cava 1
Changsha 1
Colomiers 1
Easton 1
Fontanarosa 1
Giulianova 1
Groningen 1
Guangzhou 1
Gunzenhausen 1
Hefei 1
Hongtong 1
Istanbul 1
Totale 1.285
Nome #
Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury. 105
Effects of sildenafil on the gastrocnemius and cardiac muscles of rats in a model of prolonged moderate exercise training. 99
G-CSF Contributes at the Healing of Tunica Media of Arteriotomy-Injured Rat Carotids by Promoting Differentiation of Vascular Smooth Muscle Cells. 90
Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab. 87
Local inhibition of ornithine decarboxylase reduces vascular stenosis in a murine model of carotid injury 73
Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α. 73
Effects of chronic administration of β-blockers on airway responsiveness in a murine model of heart failure. 71
Adiponectin elevation by telmisartan ameliorates ischaemic myocardium in Zucker diabetic fatty rats with metabolic syndrome. 71
Effect of Prolonged Moderate Exercise on the Changes of Nonneuronal Cells in Early Myocardial Infarction. 66
Farmacologia dell’ossido nitrico 63
AT1-receptor blockade: Protective effects of irbesartan in cardiomyocytes under hypoxic stress. 62
Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling. 61
Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures 60
Rosiglitazone Reduces the Inflammatory Response in a Model of Vascular Injury in Rats 59
Inflammatory events in a vascular remodeling model induced by surgical injury to the rat carotid artery. 59
PPARα mediates the anti-inflammatory effect of simvastatin in an experimental model of zymosan-induced multiple organ failure 54
Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome 53
Zucher Diabetic Fatty rats with metabolic syndrome are protected from acute myocardial infarction by three weeks treatment with telmisartan 53
Evaluation of unsulfated biotechnological chondroitin in a knee osteoarthritis mouse model as a potential novel functional ingredient in nutraceuticals and pharmaceuticals 51
Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction 51
Addition of the aldose reductase inhibitor benzofuroxane derivative BF-5M to prolonged and moderate exercise training enhanced protection of the rat heart from type-1 diabetes 50
Atrial fibrillation: epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors 49
Sistema istaminergico 49
Sistema serotoninergico 47
Cardioprotective effect of a moderate and prolonged exercise training involves sirtuin pathway. 47
Myocardial adeno-associated virus serotype 6-βARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure 46
An in vitro study to assess the effect of hyaluronan-based gels on muscle-derived cells: Highlighting a new perspective in regenerative medicine 45
Antimicrobial Peptides Human Beta-Defensin-2 and -3 Protect the Gut During Candida albicans Infections Enhancing the Intestinal Barrier Integrity: In Vitro Study 45
Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch 27
Role of statins and mevalonate pathway on impaired HDAC2 activity induced by oxidative stress in human airway epithelial cells. 27
COVID-19 and atrial fibrillation: Intercepting lines 24
Streptozotocin-Induced Type 1 and 2 Diabetes Mellitus Mouse Models Show Different Functional, Cellular and Molecular Patterns of Diabetic Cardiomyopathy 18
Hyaluronic acid-based fillers in patients with autoimmune inflammatory diseases 17
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 14
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database 14
Q-switched Nd:YAG laser protects human keratinocytes from oxidative stress and inflammation via AhR–Nrf2 pathway 13
Do peripheral neuropathies differ among immune checkpoint inhibitors? Reports from the European post-marketing surveillance database in the past 10 years 11
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis 10
Effects of sacubitril-valsartan on aging-related cardiac dysfunction 9
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects 6
Totale 1.929
Categoria #
all - tutte 8.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.595


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020105 0 0 0 0 20 9 31 7 11 13 11 3
2020/2021221 15 0 24 14 45 2 34 16 6 30 26 9
2021/2022185 19 0 1 11 62 1 4 2 6 12 14 53
2022/2023605 37 16 20 75 43 61 10 46 259 8 7 23
2023/2024273 29 8 22 19 68 26 4 8 6 13 25 45
2024/2025130 13 10 12 36 59 0 0 0 0 0 0 0
Totale 1.929